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Prevention of Surgical-Site Infections
To the Editor: I am concerned about the gener-
alizability of the findings of Bode et al. (Jan. 7 
issue)1 regarding the identification of nasal car-
riers of Staphylococcus aureus and the subsequent 
use of mupirocin nasal ointment and chlorhexi-
dine soap. First, it is unclear how the researchers 
identified patients who were expected to be hos-
pitalized for 4 or more days, since no specific 
protocol is provided. Second, key surgical data 
are lacking, despite the preponderance of surgi-
cal patients (88%). No data are provided on the 
appropriateness of antimicrobial prophylaxis, in 
particular the timing of administration; 84 of 
828 surgical patients (10%) received no prophy-
laxis. Similarly, no data are provided to explain the 
high rate of infection: among surgical patients, 
S. aureus infection developed in 3.6% of those re-
ceiving prophylaxis and 8.4% of those receiving 
placebo; 11 to 12% of patients had non–S. aureus 
infection. Would the intervention be as effective 
in a hospital with lower baseline rates of infec-
tion? Finally, it is unclear whether such a screen-
ing protocol would work in settings with a high 
rate of methicillin-resistant S. aureus infection, as 
is the case in many community hospitals.2
Deverick J. Anderson, M.D., M.P.H.
Duke University Medical Center 
Durham, NC 
dja@duke.edu
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To the Editor: The study by Bode et al. high-
lights the value of mupirocin–chlorhexidine pro-
phylaxis in preventing nosocomial S. aureus infec-
tion. Although resistance rates are low in the 
Netherlands, where Bode et al. conducted their 
study, our experience at the Providence Veterans 
Affairs Medical Center has shown that increased 
use of mupirocin can result in increased rates of 
resistance in methicillin-resistant S. aureus.
Our targeted presurgical surveillance and de-
colonization program for methicillin-resistant 
S. aureus with mupirocin–chlorhexidine started in 
2006, followed by facility-wide surveillance and 
provider-initiated decolonization in 2007. Using 
Pearson correlation coefficients, we have been 
evaluating mupirocin resistance in S. aureus since 
June 2004 and assessing the effect of facility-
level use of mupirocin.1-4 In 980 isolates of meth-
icillin-resistant S. aureus, we found that an increase 
in the monthly use of mupirocin had a significant 
association with subsequent increases in low-level 
resistance after 1 month (P = 0.05) and in high-
level resistance after 2 months (P = 0.03). Mupiro-
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cin resistance in methicillin-susceptible S. aureus 
was uncommon during the 4.5-year period (9 cases 
of resistance in 342 isolates), and the use of mupi-
rocin was not correlated with lagged resistance in 
the subsequent 12 months. These data suggest an 
ecologic association between mupirocin use and 
resistance in methicillin-resistant S. aureus. These 
findings have implications for facilities institut-
ing decolonization programs, since the increased 
use of mupirocin may reduce the drug’s effec-
tiveness.
Kerry L. LaPlante, Pharm.D.
University of Rhode Island 
Kingston, RI 
kerrytedesco@uri.edu
Aisling R. Caffrey, M.S., Ph.D.
Veterans Affairs Medical Center 
Providence, RI
Kalpana Gupta, M.D., M.P.H.
Massachusetts Veterans Epidemiology Research Information  
 Center 
Boston, MA
No potential conflict of interest relevant to this letter was re-
ported.
Cookson BD. The emergence of mupirocin resistance: a chal-1. 
lenge to infection control and antibiotic prescribing practice. J An-
timicrob Chemother 1998;41:11-8.
Deshpande LM, Fix AM, Pfaller MA, Jones RN. Emerging 2. 
elevated mupirocin resistance rates among staphylococcal iso-
lates in the SENTRY Antimicrobial Surveillance Program (2000): 
correlations of results from disk diffusion, Etest and reference 
dilution methods. Diagn Microbiol Infect Dis 2002;42:283-90.
M100-S19: performance standards for antimicrobial suscep-3. 
tibility testing: 19th informational supplement. Wayne, PA: Clini-
cal and Laboratory Standards Institute, 2009.
Patel JB, Gorwitz RJ, Jernigan JA. Mupirocin resistance. Clin 4. 
Infect Dis 2009;49:935-41.
To the Editor: We do not believe that preopera-
tive S. aureus screening and decolonization provides 
only a marginal benefit or should be reserved for 
the highest-risk surgical patients, as suggested by 
Wenzel1 in the editorial accompanying the article 
by Bode et al. S. aureus, a virulent pathogen, can 
cause a substantial number of surgical-site infec-
tions and deaths across a wide spectrum of pa-
tients.2 
A total of 91 patients with S. aureus coloniza-
tion in three studies3-5 underwent preoperative 
screening and decolonization; no S. aureus infec-
tions developed in these patients, as compared 
with 32 of 533 patients (6%) with such coloniza-
tion who received chlorhexidine antisepsis but not 
decolonization (P = 0.009). Screening also facili-
tates better perioperative prophylaxis (e.g., for 
methicillin-resistant S. aureus). Without screening, 
appropriate switching from cefazolin to vancomy-
cin often does not happen. In one cited study,4 
surgeons routinely switched antibiotics, and methi-
cillin-susceptible S. aureus caused the only surgical-
site infection in a patient who did not receive 
mupirocin. In another study,3 surgeons did not 
switch antibiotics, and methicillin-resistant S. au-
reus was rare and prophylaxis usually appropri-
ate. In a third study,5 which was focused on 
patients with methicillin-resistant S. aureus, those 
who underwent decolonization also received ap-
propriate perioperative prophylaxis, whereas the 
other patients who were colonized with methi-
cillin-resistant S. aureus usually did not receive a 
glycopeptide, a factor that may have influenced the 
development of 29 surgical-site infections with 
the methicillin-resistant strain. 
One advantage of screening is that colonized 
patients can be isolated to prevent spread. More 
than 30 studies have shown that active detection 
and isolation were effective at controlling meth-
icillin-resistant S. aureus infections among surgi-
cal patients, and 12 studies of cost-effectiveness 
reported savings with such prophylaxis. 
Barry M. Farr, M.D.
University of Virginia Health System 
Charlottesville, VA
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To the Editor: In their study comparing chlor-
hexidine–alcohol with povidone–iodine for sur-
gical-site antisepsis, Darouiche et al. (Jan. 7 issue)1 
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